iBIO STOCK PRICE RETREATS AFTER EARLIER SURGE FROM GE NEWS

http://youtu.be/7INgGJY-ht4 Shares in Newark-based biotech company iBIO  were on  roll for a time. After slumping to about 70 cents a share in June, the company saw...

BLOOM ENERGY SERVER TO POWER CALIFORNIA COMPANY

Life Technologies Corp. announced it will use a fuel cell system to self-generate electricity for its company headquarters, along with its manufacturing and distribution...

ASTRAZENECA EARNINGS DOWN AS GENERIC COMPETITION TAKES TOLL

AstraZeneca reported lower revenues and earnings as patents expired on blockbuster drugs and generic competition increased. One of those drugs is Seroquel,   developed...

DUPONT EARNINGS DOWN SLIGHTLY AFTER INVISTA, HERBICIDE CHARGES

Graphic based on an image from DuPont illustrating the use of the company's technologies in aircraft. DuPont Co. posted slightly lower earnings in the second...

AMAZON.COM LAUNCHES TUITION PROGRAM AIMED AT TECH COLLEGE STUDENTS

Amazon.com announced  an education program that targets those seeking two-year degrees or technical and vocational certifications. Known as Career Choice, the program is unique because...

DuPont technology helps extend range of electric vehicle

A recent breakthrough in electric vehicle motor technology from Japan-based SIM-Drive Corp. extends driving range 30 percent beyond today’s mass-produced extended-range vehicles. Aiding the performance were...

UD professor reports milestone in fuel cell membrane research

t looks like a plastic candy wrapper that’s been charred on both sides, but it may hold the solution to commercially viable fuel cells. About...

AstraZeneca exits cancer center business

AstraZeneca  has completed the previously disclosed  sale of the assets of its subsidiary, Aptium Oncology. Aptium Oncology provided outpatient oncology management and consulting services in...

A new look for the website

You might have noticed that this humble website has a new look.  The credit goes to New WordPress Themes http://newwpthemes.com. The company has rolled out themes that...

Bristol-Myers Squibb, AstraZeneca expand diabetes alliance

Bristol-Myers Squibb and AstraZeneca announced that, following the completion of Bristol-Myers Squibb’s acquisition of Amylin, the companies will enter into collaboration arrangements, regarding the...

Wilmington-area lab expands services

SL Pharma Labs announced an expansion of its services to include quality control analytical and microbiological support for marketed pharmaceutical products. “Global pharmaceutical companies are...

AstraZeneca completes $1.26 billion acquisition of Ardea

AstraZeneca has completed its $1.26 billion acquisition of San Diego-based drug development company, Ardea Biosciences, Inc. The merger was approved by Ardea’s stockholders. Each outstanding...

AstraZeneca, Rigel sign deal for potential new treatment for chronic asthma

AstraZeneca and Rigel Pharmaceuticals Inc. Tuesday  announced an  agreement for the global development and commercialization for a drug  now being investigated as a treatment...

Microsoft tablet computer aimed at taking on IPad – Bloomberg

Microsoft Corp. unveiled its own Windows-powered tablet computer called Surface, altering its strategy of focusing on software and relying on partners to make the...

Newark-based iBio makes progress on patent

The U.S. Patent Office has accepted a patent application for the iBio Inc. iBioModulator platform. The platform aims to improve the potency and effectiveness...

AstraZeneca among pharma companies seeking antibiotics answers

   A growing worry in medicine is bugs’ increasing resistance to antibiotics. At AstraZeneca’s research centre near Boston, scientists toil to find new weapons. Machines...

DuPont opens new office building

DuPont last week opened a new five-story, 220,000 square foot office building at its Chestnut Run facility – incorporating sustainability into the building design...

SDIX reports loss, partnership with drug company

 SDIX, a Glasgow, Del. provider of biotechnology-based products and services reported a loss for the quarter and a partnership with a drug company. Revenue...

DuPont acquires remainder of soy venture

DuPont,  on May 1,  took  full ownership of St. Louis-based soy-based ingredients  joint venture  Solae. DuPont previously owned 72 percent  of the joint venture...

WEEK IN REVIEW – A tale of 2 pharma companies, casino earnings perk up

Most businesspeople in Delaware know little about Incyte. The pharmaceutical development company, based in DuPont research space at the Experimental Station has quietly built a...
Advertisement